What is Aflac's cancer — issuances?

Aflac (AFL) reported cancer — issuances of $221M in Q1 2026.

How has Aflac's cancer — issuances changed year-over-year?

Aflac's cancer — issuances increased by 2.8% year-over-year, from $215M to $221M.

What is the long-term trend for Aflac's cancer — issuances?

Over 4 years (2021 to 2025), Aflac's cancer — issuances has grown at a 0.1% compound annual growth rate (CAGR), from $1.13B to $1.14B.

What does cancer — issuances mean?

The volume of new cancer insurance policies issued during the period, representing the inflow of new business. This is a key indicator of market demand and sales force effectiveness.

Aflac AFL Cancer — Issuances

Other product segments

Other

$476M+102%

Critical care

$215M-4.9%

Life insurance

$185M-7.0%

Accident

$116M+2.7%

Disability

$115M-8.0%

Hospital indemnity

$95M+3.3%

Medical and other health

$15M-80.0%

Dental/vision

$14M-6.7%

Similar metrics at other companies

EQHHealth — Issuances

$0—

GLHealth — Issuances

$328.51M+55.2%

GLOther — Issuances

$5.21M-0.1%

CRBGLife Insurance — Issuances

$170M+11.1%

KKROther — Issuances

$122.07M+19.2%

GLLife — Issuances

$320.5M-8.0%

Other financials

Income statement

See full

Revenue$4.3B+27.9%

Net income$1.0B+3,414%

EPS (diluted)$1.98+3,860%

Balance sheet

See full

Cash & equivalents$5.7B+8.1%

Total debt$8.0B+1.8%

Total equity$30.0B+13.8%

Total assets$116.28B-3.3%

Cash flow

See full

Operating cash flow$968.0M+64.3%

Valuation

See full

Market cap$60.18B+7.8%

Enterprise value$62.52B+6.9%

P/E13×-2.6×

P/S3.3×0.0×

Profitability

See full

Net margin25.6%+4.3pp

Returns & leverage

See full

Return on equity16.5%+2.1pp

Debt / equity0.3×0.0×

Where this comes from

Reported directly by Aflac in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance.

The official record: Aflac’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aflac's cancer — issuances.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aflac's cancer — issuances?: Aflac (AFL) reported cancer — issuances of $221M in Q1 2026.
How has Aflac's cancer — issuances changed year-over-year?: Aflac's cancer — issuances increased by 2.8% year-over-year, from $215M to $221M.
What is the long-term trend for Aflac's cancer — issuances?: Over 4 years (2021 to 2025), Aflac's cancer — issuances has grown at a 0.1% compound annual growth rate (CAGR), from $1.13B to $1.14B.
What does cancer — issuances mean?: The volume of new cancer insurance policies issued during the period, representing the inflow of new business. This is a key indicator of market demand and sales force effectiveness.